^
No biomarker
T Cell Non-Hodgkin Lymphoma
nelarabine
Sensitive
:
A1
TNFRSF8 positive
Cutaneous T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
bexarotene oral
Sensitive
:
A1
TNFRSF8 expression
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
belinostat
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
brentuximab vedotin
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
vorinostat
Sensitive
:
A1
IL2RA expression
Cutaneous T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
No biomarker
Peripheral T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
No biomarker
Cutaneous T-cell Lymphoma
denileukin diftitox
Sensitive
:
A1
ALK positive
Peripheral T-cell Lymphoma
crizotinib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
etoposide IV
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
cyclophosphamide oral
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
etoposide IV + cyclophosphamide oral
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
bortezomib
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
bendamustine
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
alemtuzumab
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
lenalidomide
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
gemcitabine
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
pralatrexate
Sensitive
:
A2
No biomarker
Peripheral T-cell Lymphoma
RP6530
Sensitive
:
B
No biomarker
Cutaneous T-cell Lymphoma
RP6530
Sensitive
:
B
ALK negative
T Cell Non-Hodgkin Lymphoma
brentuximab vedotin
Sensitive
:
B
ALK positive
T Cell Non-Hodgkin Lymphoma
ceritinib
Sensitive
:
C1
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our